Yves Bikorimana: When Cancer Triggers Blood Clotting – Understanding Trousseau Syndrome
Yves Bikorimana, CEO at MedData – Rwanda and Lab Scientist at The University Teaching Hospital of Kigali – Chuk, shared a post on LinkedIn:
“When Cancer Triggers Blood Clotting: Understanding Trousseau Syndrome
Cancer – associated thrombosis is a critical yet sometimes under-recognized cause of thromboembolic events.
One classic example is Trousseau syndrome, a paraneoplastic condition first described by Armand Trousseau, in which cancer creates a hypercoagulable (pro-clotting) state.
How does this happen?
Malignancies can activate the coagulation system through several biological mechanisms:
- Tumor cells release tissue factor and procoagulant microparticles
- Mucin – producing tumors interact with platelets and selectins
- Systemic inflammation increases thrombin generation
Clinical consequences may include:
- Migratory thrombophlebitis
- Recurrent venous thromboembolism
- Arterial thrombosis and unexplained (cryptogenic) stroke
This condition is most commonly associated with cancers such as pancreatic, gastric, and lung malignancies.
Key takeaway for clinicians:
- Unexplained or recurrent thrombosis – especially in unusual locations – should raise suspicion of an underlying (occult) malignancy.
- Understanding cancer-associated hypercoagulability is essential for early diagnosis, accurate risk assessment, and improved patient management.”
Stay updated with Hemostasis Today.
-
Jun 26, 2026, 01:48Michael Stark: Highlights from ISBT 2026 on RBC Transfusion and NEC in Neonates
-
Jun 25, 2026, 19:32Javier M. Floren: A Blood Clot Is One of the Most Impressive Examples of Teamwork You’ll Ever See
-
Jun 25, 2026, 19:31Marcin Krzysztof Maniak: Linking Tissue Mechanics to Inflammation in Health and Disease
-
Jun 25, 2026, 19:29Deepak Rawat: A Diagnosis Like Immune Thrombocytopenia Changes Your Perspective
-
Jun 25, 2026, 19:27Srikanth R.: Don’t Ignore Your Health While Chasing Success
-
Jun 25, 2026, 19:27Jamie Nash: Delighted to Receive the BBTS Race and Sanger Award 2026
-
Jun 25, 2026, 15:56Wolfgang Miesbach: Building the Future of Gene Therapy – From Centre Readiness to Long-Term Patient Care
-
Jun 25, 2026, 15:46Amber Yates: Making a Meaningful Difference for People Living with Sickle Cell Disease
-
Jun 25, 2026, 15:43Nancy Cavey: Navigating Disability Benefits for Patients with Immune Thrombocytopenia